BRD7 anticorps (C-Term)
-
- Antigène Voir toutes BRD7 Anticorps
- BRD7 (Bromodomain Containing 7 (BRD7))
-
Épitope
- C-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp BRD7 est non-conjugé
-
Application
- Western Blotting (WB)
- Purification
- Purified
- Immunogène
- BRD7 antibody was raised in rabbit using the C terminal of BRD7 as the immunogen
- Top Product
- Discover our top product BRD7 Anticorps primaire
-
-
- Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
BRD7 Blocking Peptide, catalog no. 33R-4343, is also available for use as a blocking control in assays to test for specificity of this BRD7 antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Antigène
- BRD7 (Bromodomain Containing 7 (BRD7))
- Autre désignation
- BRD7 (BRD7 Produits)
- Synonymes
- anticorps zgc:66347, anticorps wu:fc95f02, anticorps MGC79478, anticorps BRD7, anticorps BP75, anticorps CELTIX1, anticorps NAG4, anticorps Ptpn13ip, anticorps bromodomain containing 7 L homeolog, anticorps bromodomain containing 7, anticorps brd7.L, anticorps brd7, anticorps BRD7, anticorps Brd7
- Sujet
- BRD7 is an activator of the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. It induces dephosphorylation of GSK3B at 'Tyr-216'. Synonyms: Polyclonal BRD7 antibody, Anti-BRD7 antibody, bromodomain containing 7 antibody, BP75 antibody, CELTIX1 antibody, NAG4 antibody.
-